Biogen stock falls after FDA calls for federal investigation into Alzheimer's drug approval
Acting FDA Commissioner Woodcock asked the independent Office of the Inspector General to investigate interactions between the agency...
Full Article
Biogen stock falls after FDA calls for federal investigation into Alzheimer's drug approval
Upworthy
0 shares
1 views
You might like
Related news coverage
FDA Calls for Investigation of the Approval of Biogen’s Alzheimer’s Drug amid Backlash
HNGN
The FDA chief, Janet Woodcock, M.D., has requested for an investigation of Biogen's Alzheimer's drug after recognizing a..
Advertisement
More coverage
FDA head calls for inquiry into Alzheimer's drug review
SeattlePI.com
WASHINGTON (AP) — The acting head of the Food and Drug Administration on Friday called for a government investigation into highly..
-
F.D.A. Requests Federal Investigation of Alzheimer’s Drug Approval
NYTimes.com
-
Biogen stock falls as FDA may investigate Alzheimer's drug approval process
MarketWatch
-
FDA head calls for probe into Alzheimer's drug review
SeattlePI.com
-
FDA calls for investigation into controversial Alzheimer's drug approval
Upworthy